PMA device
ProACT Adjustable Continence Therapy for Men
Uromedica, Inc. · Device, Incontinence, Mechanical/Hydraulic (EZY, Class III) · First FDA decision Nov 24, 2015, newest Oct 3, 2025Overactive bladder and urinary incontinence
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
2
Naming "ProACT Adjustable Continence"
MAUDE reports
91
Brand "ProACT Adjustable Continence", since 2015
PubMed studies
0
Mentioning "ProACT Adjustable Continence"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing ProACT Adjustable Continence Therapy for Men
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- ProACT Adjustable Continence Therapy for MenPMA supplement
P130018-S004 · Decided Oct 3, 2025 · 30 days after receipt · Normal 180 Day Track No User Fee
Device type: Device, incontinence, mechanical/hydraulic (EZY) · GI, Urology & Nephrology
- PROACT ADJUSTABLE CONTINENCE THERAPY FOR MENPMA supplement
P130018-S001 · Decided Nov 2, 2016 · 317 days after receipt · Normal 180 Day Track No User Fee
Device type: Device, incontinence, mechanical/hydraulic (EZY) · GI, Urology & Nephrology
P130018 · Decided Nov 24, 2015 · 890 days after receipt
Device type: Device, incontinence, mechanical/hydraulic (EZY) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "ProACT Adjustable Continence", any status and sponsor, newest update first.
- ProACT Post-Approval StudyRecruiting
UromedicaNot on our public-company list
NCT03767595 · 145 participants (planned) · Start Feb 19, 2019 · Primary completion Dec 31, 2031
Device: ProACT Adjustable Continence Therapy for Men · For: Stress Urinary Incontinence
Sites: Los Angeles, California; Santa Barbara, California; Denver, Colorado · 14 sites in all
UromedicaNot on our public-company list
NCT00277095 · 123 participants · Start Aug 2005 · Primary completion Feb 2009
Device: ProACT (Adjustable Continence Therapy) · For: Urinary Incontinence
Sites: Tucson, Arizona; Los Angeles, California; Pembroke Pines, Florida · 10 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "ProACT Adjustable Continence", and for the whole product code for context.
This brand
91 reports: 4 malfunction, 86 injury, 0 death
Whole product code EZY
16,309 reports: 465 malfunction, 15,829 injury, 8 death
Newest reports for this brand
MW6004291 · Received Oct 21, 2026
Device type: Device, Incontinence, Mechanical/Hydraulic (EZY)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Insufficient Information
3003477176-2026-00018 · Received Oct 13, 2026 · Event dated Sep 2, 2026
Device type: Device, Incontinence, Mechanical/Hydraulic (EZY)
Device problem as coded: Improper or Incorrect Procedure or Method
Patient problem as coded: Internal Organ Perforation
3003477176-2026-00017 · Received Oct 12, 2026 · Event dated Jul 21, 2026
Device type: Device, Incontinence, Mechanical/Hydraulic (EZY)
Device problem as coded: Migration
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0458-2022 · Started Nov 22, 2021
Reason given: The U-channel sheaths may cause damage to ProACT implant devices when the devices are passed through the sheath during a ProACT implantation procedure.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Device, Incontinence, Mechanical/Hydraulic (EZY)
Z-1808-2020 · Started Apr 10, 2019
Reason given: Potential issue with the manufacture and inspection of U-channel sheaths in Implantation Instruments Sets. Affected U-channel sheaths may be more likely to cause damage to ProACT implant devices when passes through the sheaths.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Surgical Instruments, G-U, Manual (And Accessories) (KOA)
Published research
The most relevant PubMed records for "ProACT Adjustable Continence"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code EZY.
- AMS 800 Artificial Urinary Sphincter (with and without InhibiZone)Boston Scientific Corp · PMA 2024
- Ams Sphincter 800 Urinary ProsthesisBoston Scientific Corp · PMA 2012
- Sphincter 800 Urinary Control SystemBoston Scientific Corp · PMA 2007
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.